NCT06140524 2026-01-22
LINKER-MGUS1
Regeneron Pharmaceuticals
Phase 2 Recruiting
Clinical Trials
5 trialsNCT06762769 2025-08-01
MODIFY
University College, London
Phase 2 Recruiting
NCT05597345 2025-02-10
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
University of Rochester
Phase 2 Recruiting
NCT06183489 2024-10-18
ERASMM
European Myeloma Network B.V.
Phase 2 Recruiting
NCT04731844 2024-07-12
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
University of Rochester
Phase 2 Recruiting